OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SCTH60

Supercomnet Technologies Bhd

Electrical Components & EquipmentVerified

Supercomnet Technologies Bhd maintains a strong liquidity position, with a current ratio of 16.5, indicating significant short-term asset coverage over liabilities. The company’s debt-to-equity ratio is 0.0, reflecting a capital structure entirely equity-funded, which reduces financial leverage risk. Free cash flow is negative at -5.88 million MYR, driven by capital expenditures of -19.91 million MYR, suggesting reinvestment in operations or expansion. Profitability metrics show a return on equity (ROE) of 6.12% and return on assets (ROA) of 5.84%, both below the median for the Electrical Components & Equipment industry, which typically sees ROE and ROA in the 8-10% range. Gross profit of 43.32 million MYR on 140.09 million MYR in revenue yields a 30.9% gross margin, which is in line with industry norms but leaves room for improvement in operating efficiency. The company’s revenue is concentrated in its core manufacturing segments, with no disclosed geographic diversification beyond Malaysia. Subsidiaries Supercomal Medical Products Sdn Bhd and Supercomal Advance Cables Sdn Bhd contribute to medical and automotive product lines, but the parent company’s financials do not break out segment-specific revenue shares. This lack of transparency limits visibility into growth drivers or exposure to sector-specific risks. Looking ahead, revenue is projected to grow modestly, with no explicit guidance provided in the latest filings. Analysts have assigned a mean price target of 0.81 MYR, with a median of 0.86 MYR, and a mean recommendation of 2.33 (leaning toward "Hold"). The absence of strong-buy ratings and the low dilution risk suggest a cautious outlook, with investors prioritizing stability over aggressive growth. Risk factors include the inability to assess liquidity risk due to incomplete balance-sheet inputs and no going-concern language in source documents. The company’s dilution risk is rated as low, with no near-term pressure from share issuance or convertible instruments. However, the negative free cash flow and high capital expenditures may signal potential liquidity constraints if reinvestment does not yield returns. Recent events include the absence of material filings or transcripts, with the latest financial data dated to the HA-latest period. No significant regulatory or operational risks were disclosed in the most recent reports, though the lack of transparency in segment reporting and geographic exposure remains a concern for long-term visibility.

30-day price · SCTH+0.02 (+2.8%)
Low$0.53High$0.63Close$0.56As of13 May, 00:00 UTC
Profile
CompanySupercomnet Technologies Bhd
TickerSCTH.KL
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryElectrical Components & Equipment
AI analysis

Business. Supercomnet Technologies Bhd is a Malaysia-based manufacturer of polyvinyl chloride (PVC) compounds, cables, wires, and related components for electronic devices, medical equipment, and automotive markets, with subsidiaries focused on medical cables and automotive fuel tanks.

Classification. The company is classified under the Industrials sector, Industrial Goods business sector, and Electrical Components & Equipment industry, with a confidence level of 0.92 based on verified market data.

Supercomnet Technologies Bhd maintains a strong liquidity position, with a current ratio of 16.5, indicating significant short-term asset coverage over liabilities. The company’s debt-to-equity ratio is 0.0, reflecting a capital structure entirely equity-funded, which reduces financial leverage risk. Free cash flow is negative at -5.88 million MYR, driven by capital expenditures of -19.91 million MYR, suggesting reinvestment in operations or expansion. Profitability metrics show a return on equity (ROE) of 6.12% and return on assets (ROA) of 5.84%, both below the median for the Electrical Components & Equipment industry, which typically sees ROE and ROA in the 8-10% range. Gross profit of 43.32 million MYR on 140.09 million MYR in revenue yields a 30.9% gross margin, which is in line with industry norms but leaves room for improvement in operating efficiency. The company’s revenue is concentrated in its core manufacturing segments, with no disclosed geographic diversification beyond Malaysia. Subsidiaries Supercomal Medical Products Sdn Bhd and Supercomal Advance Cables Sdn Bhd contribute to medical and automotive product lines, but the parent company’s financials do not break out segment-specific revenue shares. This lack of transparency limits visibility into growth drivers or exposure to sector-specific risks. Looking ahead, revenue is projected to grow modestly, with no explicit guidance provided in the latest filings. Analysts have assigned a mean price target of 0.81 MYR, with a median of 0.86 MYR, and a mean recommendation of 2.33 (leaning toward "Hold"). The absence of strong-buy ratings and the low dilution risk suggest a cautious outlook, with investors prioritizing stability over aggressive growth. Risk factors include the inability to assess liquidity risk due to incomplete balance-sheet inputs and no going-concern language in source documents. The company’s dilution risk is rated as low, with no near-term pressure from share issuance or convertible instruments. However, the negative free cash flow and high capital expenditures may signal potential liquidity constraints if reinvestment does not yield returns. Recent events include the absence of material filings or transcripts, with the latest financial data dated to the HA-latest period. No significant regulatory or operational risks were disclosed in the most recent reports, though the lack of transparency in segment reporting and geographic exposure remains a concern for long-term visibility.
Key takeaways
  • Supercomnet Technologies Bhd is entirely equity-funded, with no debt and a current ratio of 16.5, indicating strong liquidity.
  • ROE and ROA are below industry medians, suggesting room for improvement in asset utilization and profitability.
  • Revenue concentration in Malaysia and lack of segment reporting limit visibility into growth drivers and geographic risk.
  • Analysts are cautious, with no strong-buy ratings and a mean recommendation of "Hold," reflecting a conservative outlook.
  • Negative free cash flow and high capital expenditures may signal reinvestment in operations but could pressure liquidity if not offset by returns.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$140.1M
Gross profit$43.3M
Operating income$33.5M
Net income$26.0M
R&D
SG&A
D&A
SBC
Operating cash flow$36.2M
CapEx-$19.9M
Free cash flow-$5.9M
Total assets$446.2M
Total liabilities$20.6M
Total equity$425.6M
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$425.6M
Net cash
Current ratio16.5
Debt/Equity0.0
ROA5.8%
ROE6.1%
Cash conversion1.4%
CapEx/Revenue-14.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
MetricSCTHActivity
Op margin23.9%9.4% medp25 9.4% · p75 9.4%top quartile
Net margin18.6%5.8% medp25 5.8% · p75 5.8%top quartile
Gross margin30.9%26.9% medp25 26.9% · p75 26.9%top quartile
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-14.2%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity0.0%106.4% medp25 106.4% · p75 106.4%bottom quartile
Observations
IR observations
Mean price target0.81 MYR
Median price target0.86 MYR
High price target1.00 MYR
Low price target0.56 MYR
Mean recommendation2.33 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.04 MYR
Last actual EPS0.03 MYR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 12:34 UTC#5f82f1dd
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 12:36 UTCJob: 09d38e47